XOMA Correlations
| XOMAO Preferred Stock | USD 25.59 0.01 0.04% |
The current 90-days correlation between XOMA and XOMA Corp is 0.19 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as XOMA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if XOMA Corporation moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
XOMA Correlation With Market
Significant diversification
The correlation between XOMA Corp. and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding XOMA Corp. and DJI in the same portfolio, assuming nothing else is changed.
XOMA |
The ability to find closely correlated positions to XOMA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace XOMA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back XOMA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling XOMA Corporation to buy it.
Moving together with XOMA Preferred Stock
| 0.63 | OSRHW | OSR Holdings, Symbol Change | PairCorr |
| 0.85 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
| 0.73 | IGC | India Globalization | PairCorr |
| 0.93 | IPA | Immunoprecise Antibodies Earnings Call This Week | PairCorr |
| 0.61 | IRD | Opus Genetics, Symbol Change | PairCorr |
| 0.61 | KOD | Kodiak Sciences | PairCorr |
| 0.81 | MGX | Metagenomi, Common Stock | PairCorr |
| 0.83 | NBY | NovaBay Pharmaceuticals | PairCorr |
| 0.61 | ONC | BeiGene, Symbol Change | PairCorr |
Moving against XOMA Preferred Stock
| 0.85 | VRPX | Virpax Pharmaceuticals | PairCorr |
| 0.76 | INO | Inovio Pharmaceuticals | PairCorr |
| 0.66 | OCEAW | Ocean Biomedical | PairCorr |
| 0.66 | ICU | LMF Acquisition Oppo | PairCorr |
| 0.62 | XFOR | X4 Pharmaceuticals | PairCorr |
| 0.51 | VINC | Vincerx Pharma, Common | PairCorr |
| 0.44 | IMTXW | Immatics Biotechnologies | PairCorr |
| 0.43 | VIRX | Viracta Therapeutics | PairCorr |
| 0.37 | PLX | Protalix Biotherapeutics | PairCorr |
| 0.31 | IVA | Inventiva Sa | PairCorr |
Related Correlations Analysis
| 0.58 | 0.34 | 0.4 | 0.37 | XOMAP | ||
| 0.58 | 0.81 | 0.83 | 0.63 | HROWL | ||
| 0.34 | 0.81 | 0.84 | 0.53 | SPNT-PB | ||
| 0.4 | 0.83 | 0.84 | 0.76 | NYMTM | ||
| 0.37 | 0.63 | 0.53 | 0.76 | SACH-PA | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between XOMA Preferred Stock performing well and XOMA Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze XOMA's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| XOMAP | 0.52 | (0.02) | (0.20) | (0.11) | 0.67 | 1.16 | 4.40 | |||
| HROWL | 0.20 | 0.03 | (0.61) | 0.97 | 0.00 | 0.53 | 1.14 | |||
| SPNT-PB | 0.15 | 0.05 | (0.59) | 1.83 | 0.00 | 0.41 | 0.92 | |||
| NYMTM | 0.35 | 0.09 | (0.11) | 0.75 | 0.02 | 1.03 | 2.86 | |||
| SACH-PA | 1.63 | 0.26 | 0.05 | 4.72 | 1.83 | 3.78 | 12.26 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in XOMA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |